VHT
vs
S
S&P/ASX 300
VHT
Over the past 12 months, VHT has underperformed S&P/ASX 300, delivering a return of 0% compared to S&P/ASX 300's +1% growth.
Stocks Performance
VHT vs S&P/ASX 300
Performance Gap
VHT vs S&P/ASX 300
Performance By Year
VHT vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Volpara Health Technologies Ltd
Glance View
Volpara Health Technologies Ltd. engages in selling the VolparaEnterprise software, which is a cloud-based breast imaging analytics product. The firm is engaged in developing digital health solutions to enable personalized breast cancer screening based on objective measurements of breast density, compression, and radiation dose. Its geographic segments include North America, Europe, the Middle East and Africa (EMEA), Asia-Pacific (APAC), and Corporate. The firm's offerings include VolparaEnterprise, which enables breast imaging providers to perform control checks; VolparaDensity, which provides objective assessment of a woman's breast density; VolparaRisk is a software that features a patient questionnaire; VolparaLive provides technologists with real-time decision support at the point of care to assess image quality, and Aspen Brest, which is a workflow software that optimizes operations and administration for breast cancer screening programs.
